Fo­cused on block­buster in­di­ca­tions, Sage touts ev­i­dence that 217 could work on in­som­nia

Af­ter whip­ping up some gid­dy block­buster ex­pec­ta­tions for their oral drug SAGE-217 in de­pres­sion, Sage Ther­a­peu­tics is back this morn­ing with an ear­ly snap­shot on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER